#STATMadness is back!
Our bracket-style tournament to find the best innovations in science & medicine from research institutions nationwide. Innovations must be published in 2026. Top 64 will be picked to compete based on originality, scientific rigor, and potential impact. https://t.co/f5k0f7EsaT
The American Society of Addiction Medicine has released the first national guidance for recognizing and treating patients who have taken medetomidine. https://t.co/L1vMSveIrP
Heading to #HLTHUSA? Join us at the STAT@HLTH stage on Nov. 18 for live conversations on AI, EHRs, and the realities of health tech, featuring leaders from Epic, WHOOP, Verily, and more.
STAT readers get a special HLTH rate with code: H26PAR_STAT. Learn more and RSVP here: https://t.co/NyN4HwWWyZ
Synchron has paused clinical trials of its second-generation brain-computer interface.
It's the first major hiccup for Synchron, one of the leading companies in a fast-growing industry aimed at helping people with disabilities like ALS and paralysis. https://t.co/5AgM3rFbGk
The American Cancer Society recommended that American men between the ages of 50 and 69 at an average risk of prostate cancer should test their prostate-specific antigen (PSA) blood levels every two years. https://t.co/bPlAxnZeyM
Two senators are introducing a bill Friday to rein in conflicts of interest on an influential federal panel that evaluates preventive medical services. https://t.co/SdEETUHGwI
Over the summer, I hung out with a bunch of teens questioning their relationships to phones. I learned a lot! About what they want vs. what lawmakers are doing, about the little science we have to answer huge questions, and about how kids are feeling.
https://t.co/dp0PLy4WZF
Synchron has paused clinical trials of its second-generation brain-computer interface. Leaders say the pause is not safety related. https://t.co/W9eRwgJKf0
“Young people are developing today. They don’t really have time for us to wait 10 years to find out how to help them."
Across the U.S., homegrown experiments aim to save kids from their phones https://t.co/GWh1vhuMfJ
The Trump administration will funnel up to $4.9 million into supporting research into ibogaine, a psychedelic that’s drawn interest as a potential treatment for PTSD and addiction. https://t.co/SqyKdZ5rgy
What does the failure of two closely watched heart disease medicines mean for the future of drug research in the field? Find out on this week's episode of "The Readout… https://t.co/cAlXupK4I3
As researchers struggle to understand phone addiction, young people are finding ways to reclaim their attention and push back against Big Tech. https://t.co/5KRD8BCZNE